These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 7956789)

  • 1. [Bromocriptine-induced pleuropneumopathy].
    Schmid PA; Suter T; Speich R; Eberli F; Greminger P
    Dtsch Med Wochenschr; 1994 Nov; 119(45):1543-6. PubMed ID: 7956789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pleuropulmonary fibrosis due to bromocriptine treatment for Parkinson's disease.
    Todman DH; Oliver WA; Edwards RL
    Clin Exp Neurol; 1990; 27():79-82. PubMed ID: 2129961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pleuropulmonary disease during bromocriptine treatment of Parkinson's disease.
    McElvaney NG; Wilcox PG; Churg A; Fleetham JA
    Arch Intern Med; 1988 Oct; 148(10):2231-6. PubMed ID: 3178380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pleuropulmonary involvement during bromocriptine treatment.
    Kinnunen E; Viljanen A
    Chest; 1988 Nov; 94(5):1034-6. PubMed ID: 3180854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bromocriptine and pulmonary responses].
    Kinnunen E; Viljanen A
    Duodecim; 1989; 105(19):1614-7. PubMed ID: 2806146
    [No Abstract]   [Full Text] [Related]  

  • 6. Pleuropulmonary changes during long-term bromocriptine treatment for Parkinson's disease.
    Lancet; 1981 Jan; 1(8210):44-5. PubMed ID: 6109080
    [No Abstract]   [Full Text] [Related]  

  • 7. [Bromocriptine in Parkinson's disease: pleuropulmonary toxicity].
    Douvier JJ; Vergeret J; Taytard A; Brottier E; Domblides P; Dubos F; Freour P
    Ann Med Interne (Paris); 1985; 136(5):416-8. PubMed ID: 4062141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pleural effusion and constrictive pericarditis secondary to bromocriptine treatment].
    Saura J; Aguilar M; Alió J
    Neurologia; 1991 Nov; 6(9):331-3. PubMed ID: 1809340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pleuropneumopathy caused by bromocriptine in a patient with Parkinson disease. Review of the literature apropos of a new case].
    Debove P; Simon F; Vaylet F; Renard JL; L'Her P
    Ann Med Interne (Paris); 1998 Apr; 149(3):167-71. PubMed ID: 11490541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pleural effusion induced by bromocriptine].
    Diot E; Diot P; Le Rolland A; Jonville AP; Lasfargues G; Lemarie E; Lavandier M; Guilmot JL
    Rev Mal Respir; 1990; 7(2):175-7. PubMed ID: 2320790
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleuropulmonary changes during treatment of Parkinson's disease with a long-acting ergot derivative, cabergoline.
    Frans E; Dom R; Demedts M
    Eur Respir J; 1992 Feb; 5(2):263-5. PubMed ID: 1348483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Combined treatment of the early stages of Parkinson's syndrome with bromocriptine and levodopa. The results of a multicenter study].
    Fischer PA; Przuntek H; Majer M; Welzel D
    Dtsch Med Wochenschr; 1984 Aug; 109(34):1279-83. PubMed ID: 6381019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Pleuropulmonary fibrosis and bromocriptine].
    Vergeret J; Barat M; Taytard A; Bellvert P; Domblides P; Douvier JJ; Fréour P
    Sem Hop; 1984 Mar; 60(11):741-4. PubMed ID: 6324351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pergolide-induced pleural effusion in a patient with juvenile parkinsonism].
    Kuwabara T
    Rinsho Shinkeigaku; 2002 Aug; 42(8):757-60. PubMed ID: 12701223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleural disease during treatment with bromocriptine in patients previously exposed to asbestos.
    Hillerdal G; Lee J; Blomkvist A; Rask-Andersen A; Uddenfeldt M; Koyi H; Rasmussen E
    Eur Respir J; 1997 Dec; 10(12):2711-5. PubMed ID: 9493648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pleural effusion and severe edema of the lower limbs induced by bromocriptine].
    Messiaen T; Lefebvre C; Weynand B; Pieters T
    Rev Med Interne; 1996; 17(8):680-3. PubMed ID: 8881198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pleural effusion during bromocriptine exposure in two patients with pre-existing asbestos pleural plaques: a relationship?
    Knoop C; Mairesse M; Lenclud C; Gevenois PA; De Vuyst P
    Eur Respir J; 1997 Dec; 10(12):2898-901. PubMed ID: 9493681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pleuro-pulmonary changes after bromocriptine treatment of parkinsonism].
    Bøttcher J; Grøn U
    Ugeskr Laeger; 1981 Oct; 143(41):2648-9. PubMed ID: 7303288
    [No Abstract]   [Full Text] [Related]  

  • 19. Hypersexuality--a complication of dopaminergic therapy in Parkinson's disease.
    Vogel HP; Schiffter R
    Pharmacopsychiatria; 1983 Jul; 16(4):107-10. PubMed ID: 6685318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levodopa, bromocriptine and selegiline modify cardiovascular responses in Parkinson's disease.
    Haapaniemi TH; Kallio MA; Korpelainen JT; Suominen K; Tolonen U; Sotaniemi KA; Myllylä VV
    J Neurol; 2000 Nov; 247(11):868-74. PubMed ID: 11151420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.